Hormonal effects of Depo-Provera in cervical smears: A comparison with triphasil and postmenopausal effects

Cancer

Volumn 96, Issue 2, 2002, Pages 74-82

  Kaptain, Stamatina ^a   Bloom, Leonard I ^b   Weir, Michele M ^c  

^a St Joseph's Wayne Hospital   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Cervical smears; Depot medroxyprogesterone acetate (Depo Provera DP ); Hormonal effects; Levonorgestrel and ethinyl estradiol (Triphasil TP ); Postmenopausal

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MUCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CELL MATURATION; CELL NUCLEUS; CYTOLYSIS; ENDOMETRIUM CELL; FEMALE; HISTIOCYTE; HORMONAL THERAPY; HUMAN; LACTOBACILLUS; MAJOR CLINICAL STUDY; PARAKERATOSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SQUAMOUS CELL; UTERINE CERVIX CYTOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVIX UTERI; CONTRACEPTIVE AGENTS, FEMALE; ETHINYL ESTRADIOL-NORGESTREL COMBINATION; FEMALE; HUMANS; LEVONORGESTREL; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POSTMENOPAUSE; VAGINAL SMEARS;

EID: 0037171679     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10476     Document Type: Article

References (17)

1. Effects of Depot-medroxyprogesterone acetate as a contraceptive agent
2. Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA)
3. Depot-Medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia
4. Intraepithelial cervical neoplasia in women using intrauterine devices and long-acting injectable progestogens as contraceptives
5. Risk of cervical dysplasia in users of oral contraceptives, intrauterine devices and depot-medroxyprogesterone acetate
6. History of long-term use of Depo-medroxyprogesterone acetate in patients with cervical dysplasia; case-control analysis nested in a cohort study
7. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas the uterine cervix
8. Cervical cytology associated with medroxyprogesterone acetate contraception
9. Epithelial cell abnormality in the Depo-Provera patient: A diagnostic pitfall
10. Cytologic findings on (Papanicolaou) smears of patients on Depot-Provera
11. Squamous intraepithelial lesions following diagnoses of atypical squamous cells of undetermined significance (ASCUS) in progesterone-treated women: Comparison with an untreated control group
12. Underestimation of cervical lesion severity in cytology specimens from patients receiving long-term antifertility treatment
13. Cytologic changes in cervical smears associated with prolonged use of Depo-Medroxyprogesterone acetate
14. Cytologic findings in cervical smears in patients using intramuscular medroxyprogesterone acetate (DepoProvera) for contraception
15. Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II on the vaginal epithelium of Rhesus monkeys
16. Cytologic changes following the use of oral contraceptives